Status:
COMPLETED
Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome
Lead Sponsor:
Vanderbilt University Medical Center
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Chronic Interstitial Cystitis
Bladder Pain Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a severe pain condition affecting 3-8 million people in the United States lacking treatments that work. Emotional suffering is common in IC/BPS ...
Detailed Description
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a debilitating, incurable, and costly pain condition affecting approximately 3-8 million individuals in the United States and is extremely chall...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Diagnosis of IC/BPS as given by providers or indicated by assessments
Exclusion
- Comorbid neurological conditions including spinal cord injury or systematic neurologic illnesses, or central nervous system diseases such as brain tumor or stroke
- Current or history of diagnosis of primary psychotic or major thought disorder within the past five years
- Hospitalization for psychiatric reasons other than suicidal ideation, homicidal ideation, and/or PTSD (within the past 5 years)
- Psychiatric or behavioral conditions in which symptoms are unstable or severe (e.g. current delirium, mania, psychosis, suicidal ideation, homicidal ideation, substance abuse dependency) reported within the past six months
- Non-English speaking
- Presenting symptoms at time of screening that would interfere with participation, specifically active suicidal ideation with intent to harm oneself or active delusional or psychotic thinking
- Difficulties or limitations communicating over the telephone
- Any planned life events that would interfere with participating in the key elements of the study
- Any major active medical issues that could preclude participation
- Currently being treated for cancer
- Cancer-related pain
- Currently engaged in individual counseling/psychotherapy or unwilling to pause this treatment for the trial duration
Key Trial Info
Start Date :
July 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 16 2023
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT04275297
Start Date
July 13 2020
End Date
June 16 2023
Last Update
August 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37212